358 related articles for article (PubMed ID: 19674198)
1. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
4. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
6. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Ohashi K; Nemoto T; Nakamura K; Nemori R
Cancer; 2000 May; 88(10):2201-9. PubMed ID: 10820340
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
9. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
[TBL] [Abstract][Full Text] [Related]
10. Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
Bister V; Mäkitalo L; Jeskanen L; Saarialho-Kere U
J Cutan Pathol; 2007 Dec; 34(12):889-98. PubMed ID: 18001410
[TBL] [Abstract][Full Text] [Related]
11. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
12. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
13. Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma.
Sawatsubashi M; Mizokami H; Tokunaga O; Shin T
Mod Pathol; 1998 Sep; 11(9):878-85. PubMed ID: 9758368
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.
Aharinejad S; Krenn K; Zuckermann A; Schäfer R; Paulus P; Seebacher G; Wolner E; Grimm M
Eur J Cardiothorac Surg; 2007 Jul; 32(1):48-51. PubMed ID: 17482473
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
17. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
18. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Barros SS; Henriques ÁC; Pereira KM; de Medeiros AM; Galvão HC; Freitas Rde A
Arch Oral Biol; 2011 Aug; 56(8):752-60. PubMed ID: 21255765
[TBL] [Abstract][Full Text] [Related]
20. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract.
Dünne AA; Sesterhenn A; Gerisch A; Teymoortash A; Kuropkat C; Werner JA
Anticancer Res; 2003; 23(3B):2233-9. PubMed ID: 12894497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
